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Abstract
Background: A high body mass index (BMI) is associated with an increased risk of mortality from coronary heart
disease (CHD); however, a low BMI may also be associated with an increased mortality risk. There is limited
information on the relation of incident CHD risk across a wide range of BMI, particularly in women. We examined
the relation between BMI and incident CHD overall and across different risk factors of the disease in the Million
Women Study.
Methods: 1.2 million women (mean age = 56 years) participants without heart disease, stroke, or cancer (except
non-melanoma skin cancer) at baseline (1996 to 2001) were followed prospectively for 9 years on average.
Adjusted relative risks and 20-year cumulative incidence from age 55 to 74 years were calculated for CHD using
Cox regression.
Results: After excluding the first 4 years of follow-up, we found that 32,465 women had a first coronary event
(hospitalization or death) during follow-up. The adjusted relative risk for incident CHD per 5 kg/m2 increase in BMI
was 1.23 (95% confidence interval (CI) 1.22 to 1.25). The cumulative incidence of CHD from age 55 to 74 years
increased progressively with BMI, from 1 in 11 (95% CI 1 in10 to 12) for BMI of 20 kg/m2, to 1 in 6(95% CI 1 in 5 to
7) for BMI of 34 kg/m2. A 10 kg/m2 increase in BMI conferred a similar risk to a 5-year increment in chronological
age. The 20 year cumulative incidence increased with BMI in smokers and non-smokers, alcohol drinkers and non-
drinkers, physically active and inactive, and in the upper and lower socioeconomic classes. In contrast to incident
disease, the relation between BMI and CHD mortality (n = 2,431) was J-shaped. For the less than 20 kg/m2 and
≥35 kg/m2 BMI categories, the respective relative risks were 1.27 (95% CI 1.06 to 1.53) and 2.84 (95% CI 2.51 to
3.21) for CHD deaths, and 0.89 (95% CI 0.83 to 0.94) and 1.85 (95% CI 1.78 to 1.92) for incident CHD.
Conclusions: CHD incidence in women increases progressively with BMI, an association consistently seen in
different subgroups. The shape of the relation with BMI differs for incident and fatal disease.
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Background
There is growing concern about the impact of the
increasing prevalence of obesity on the burden of coron-
ary heart disease (CHD) [1], which accounts for around
15% of all deaths in the UK, USA, and other developed
nations [2-4]. Reducing this obesity-associated CHD
burden is likely to require population-level preventive
strategies. One such approach suggests shifting the
population distribution of a modifiable risk factor down-
wards to prevent the occurrence of CHD [5], but it is
unclear if this approach is relevant for obesity. Most
large-scale prospective studies have reported on CHD
mortality outcomes, showing increased coronary mortal-
ity risks in both high and low BMI groups [6-8]. The
relation between BMI and CHD may differ for incident
and fatal disease [9-11], but such findings were based on
a relatively small number of events. Large-scale studies
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that reported on incident CHD outcomes have been
limited, particularly in women, and have not compared
findings for incident and fatal CHD [12-17]. It is also
unclear if the relation between BMI and incident CHD
varies by age [8,15] or by lifestyle risk factors, particu-
larly smoking [15,18,19]. Large-scale prospective studies
may be needed to provide reliable risk estimates for
incident CHD across a wide range of BMI in the whole
population and across important subgroups. To address
these questions, we examined the relation between BMI
and CHD incidence and mortality in a cohort of over a
million women followed for an average of 9 years.
Methods
The Million Women Study is a population-based cohort
study that recruited 1.3 million women who were invited
for routine breast cancer screening between 1996 and
2001 in England and Scotland by the National Health Ser-
vice (NHS) screening program [20]. At recruitment,
women completed a health and lifestyle questionnaire,
which included questions on weight, height, sociodemo-
graphic details, medical history, and lifestyle habits. All
participants gave their written consent to take part in the
study. The Oxford and Anglia Multi-Centre Research
Ethics Committee approved the conduct of this study.
Using their individual NHS identification number,
together with other personal information, participants
were linked to NHS Central Registers for information on
deaths, cancer registration, and emigrations, and to the
NHS hospital admission databases for information on hos-
pital admissions. For participants in England, the Hospital
Episode Statistics data were available from 1 April 1997;
for participants in Scotland, the Scottish Morbidity
Records [21,22] data were available from 1 January 1981.
Hospital diagnoses and causes of death were coded using
the International Statistical Classification of Diseases and
Related Health Problems, Tenth Revision [23] (ICD-10).
Calculation, definition, and validation of anthropometric
variables
We used BMI (weight (kg) divided by height (m2), and
rounded to the nearest tenth) as our primary measure
of adiposity, as it is strongly correlated with total fat
mass [24] and provides a comparable explanatory power
of the physiologic effect of total fat mass [25]. Over-
weight and obesity were defined as a BMI of 25 to 29.9
and ≥30 kg/m2, respectively. Self-reported weight and
height were used to calculate BMI, and two different
sources were used to validate the self-reported mea-
sures. We identified 541 women who were also partici-
pants in another longitudinal study and for whom their
weight and height had been measured at the age of 53
years (at around the time that they reported their weight
and height to us), and the correlation between BMI
calculated from the measured and the self-reported data
was 0.90 [26]. A sample of 3,745 women had their weight
and height measured at general practice clinics in 2006
and 2008. BMI calculated from self-reported weight and
height at baseline on average was 1.4 ± 2.5 kg/m2
(mean ± SD) lower than that from the clinical measure-
ments, taken some 8 to 10 years later, and the correlation
between them was 0.85. In a sensitivity analysis, we used
data from the clinical measurements to evaluate the
effect of measurement error, including changes in BMI
over time, on risk estimates [27].
Definition and validation of outcomes
We defined an incident CHD event as the first hospital
admission after recruitment with a diagnosis of CHD
(ICD-10 I20 to I25) or death with CHD as the underlying
cause. In a validation study, we randomly selected 796
women with a hospital record of CHD and 864 with no
admission for vascular disease [28]. We asked general
practitioners (GPs; they hold the medical record of every
individual registered with the NHS) to report if these
women had been given this diagnosis and to provide us
with the relevant clinical information to support this
report. An adjudicating team (FLW, DC, BJC, AB, and JG)
reviewed the GPs’ diagnosis and the clinical information
provided to the investigators. The GP diagnosis of CHD
was consistent in 92% of 796 women with a hospital
record of CHD; in addition to 864 women without vascu-
lar disease hospitalization, 98% were confirmed to have
had no CHD diagnosis.
Analysis
Of the 1.3 million women recruited into the study, we
excluded 78,895 (5.8%) women who reported heart disease
or stroke at recruitment or had been admitted to hospital
for these conditions before study entry, and 44,803 (3.3%)
women who had a previous cancer registration (except
non-melanoma skin cancer), as cancer may affect weight.
Of the remaining 1.2 million women, we further excluded
64,620 (5%) women for whom BMI values were missing.
The remaining 1,178,939 women formed the basis for our
analysis.
We used Cox regression models to calculate hazard
ratios to estimate relative risks of CHD separately for
incident and mortality outcomes, using attained age as
the underlying time variable. Person-years were calcu-
lated from date of recruitment until date of first admis-
sion for CHD, death, or end of follow-up, whichever
came first. Around 5% of participants in England were
recruited before 1 April 1997, and as hospital admission
data before this date were not available, their follow-up
was calculated from this date. The follow-up of women
ended on 31 March 2008 in England and 31 December
2008 in Scotland, because hospital admission data were
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not complete after these dates. The regression models
were stratified by region of recruitment (10 regions) and
adjusted for smoking (never, past and current smokers
with consumptions of less than 5, 5 to 9, 10 to 14, 15 to
19, 20 to 24 and ≥25 cigarettes per day), weekly alcohol
consumption (0, 1 to 6, 7 to 14 and ≥15 U), strenuous
physical activity (rarely/never, once a week or less, and
more than once a week), and socioeconomic level (fifths
of Townsend deprivation index [29]). There were a few
missing values for smoking (0.7%), physical activity
(3.0%), alcohol intake (0.6%) and socioeconomic status
(0.7%). For each adjustment variable, women with miss-
ing values were assigned to a separate category.
We first calculated the incidence rate of CHD for each
year of follow-up to examine variations in disease rates
over time. Absolute risks of CHD were then calculated as
cause-specific cumulative incidences. Within 5-year age
groups (55 to 59, 60 to 64, 65 to 69, and 70 to 74 years),
incidence rates were computed from the number of cor-
onary events and time at risk. Hazard ratios from Cox
regressions were converted to absolute hazard rates by
multiplying the hazard ratios by the overall incidence rate,
divided by a weighted average of the BMI category-specific
hazard (weights were given by the total person-time at risk
for women in the corresponding BMI category) [8].
Cause-specific cumulative incidence over 5 years was cal-
culated for each age and BMI group, where appropriate,
from the absolute hazard h (in units of events per person
per year) by the formula 1 − exp (−5h) . The 20-year
cause-specific cumulative incidence between the ages of
55 and 74 years was calculated from the simple average of
the absolute hazards across the four age groups, h¯ , by the
formula 1 − exp(−20h¯) . We estimated the 20-year
cumulative incidence for the whole cohort and by sub-
groups of women classified by smoking habit, physical
activity, alcohol consumption, and socioeconomic status.
We present the risk estimates with their 95% CI.
When comparing more than two groups (such as in a
figure), relative risks are presented with their 95%
group-specific CI (g-sCI) to allow direct comparison
between any two groups [30], even if neither is the base-
line group. We conducted sensitivity analyses to assess
the effects of missing values by comparing the relative
risks based on data for all women with those women
who had no missing values for any covariate, and to
evaluate the effects of competing causes of death on the
absolute risk estimates [31]. All analyses used Stata 12.0
(StataCorp., College Station, TX, USA) [32].
Results
The characteristics of the 1,178,939 women included in
the analyses are shown in Table 1. The mean age of
women at recruitment was 56.0 ± 4.8 years (25th to 75th
percentile range 52 to 60) and the mean BMI was
26.1 ± 4.6 kg/m2. The proportions of overweight and
obese women at baseline were 35.3% and 17.1%, respec-
tively, with 5.4% having a BMI of 35 kg/m2 or over.
Mean alcohol consumption of alcohol drinkers was
4.2 ± 5.4 U/week. Compared with women with a BMI of
20 to 24.9 kg/m2, women with higher BMI were less
likely to smoke, consume alcohol, or be physically active,
and more likely to have a lower socioeconomic status
(Table 1). Women with a BMI of less than 20 kg/m2
were more likely to smoke and to have a lower socioeco-
nomic status, but less likely to drink alcohol or to be
physically active, than women with a BMI of 20 to
24.9 kg/m2.
After an average of 9 years of follow-up, there were
48,842 first coronary events including 5,097 CHD
deaths. The annual incident CHD rates for the first 4
years of follow-up were slightly lower than the rates in
the remaining follow-up period (see Additional file 1,
Figure S1). To reflect the usual disease rates in the
cohort, and to reduce the possibility of reverse causation
(that preclinical disease might affect weight), we
excluded the first 4 years of follow-up in all our subse-
quent analyses. In the remaining approximately 5 years
of follow-up, there were 32,465 women with a first cor-
onary event and 2,431 women who had CHD recorded
as the underlying cause of death, corresponding to rates
of 5.49 (95% CI 5.44 to 5.55) and 0.41 (95% CI 0.39 to
0.42) per 1,000 person-years, respectively.
From the lowest BMI categories of less than 20 kg/m2
and 20 to 22.4 kg/m2, the relative risk of incident CHD
increased progressively with BMI (Figure 1). The relative
risk for incident CHD per increment of 5 kg/m2 in BMI
was 1.29 (95% CI 1.28 to 1.30) after adjustment for age
and stratification by region. Additionally adjusting for
smoking habit, physical activity, alcohol consumption and
socioeconomic class slightly attenuated the relative risk to
1.23 (95% CI 1.22 to 1.25). For CHD mortality, the rela-
tionship with BMI was J-shaped, and the pattern of risk
differed from that of incident disease, with the relative risk
being greater for CHD mortality than for incident out-
comes among women in the lowest and highest categories
of BMI. Compared with a BMI of 22.5 to 24.9 kg/m2, the
relative risk of a BMI of less than 20 kg/m2 for CHD mor-
tality was significantly raised at 1.27 (95% CI 1.06 to 1.53),
but for incident coronary event was significantly reduced
at 0.89 (95% CI 0.83 to 0.94). For BMI ≥35 kg/m2, the rela-
tive risk of 2.84 (95% CI 2.51 to 3.21) for CHD mortality
was considerably greater than the relative risk of 1.85 (95%
CI 1.78 to 1.92) for incident disease.
The incidence of CHD increased with age, and the
progressive increase in risk with BMI was evident in
each 5-year age group from 55 to 59 years to 70 to 74
years (Figure 2; see Additional file 1, Table S1 for
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further details). Moreover, a BMI increase of 10 kg/m2
conferred an additional CHD risk similar to that conferred
by a 5-year increase in age. The 20-year cumulative inci-
dence of the disease was 12.1% (95% CI 11.9 to 12.2), that
is, about one in eight women (12%) in this cohort had a
first coronary event in the 20 years from age 55 to 74
years. Within the range of 20 to 34.9 kg/m2 (n = 28,866
incident coronary events), there was a sufficient number
of events to show that the incidence increased in a graded
manner with small increments in BMI (see Additional
file 1, Figure S2). The 20-year cumulative incidence of the
disease for a BMI of 34 kg/m2 was almost twice that for a
BMI of 21 kg/m2 (16.7% (95% CI 13.9 to 19.4%) versus
9.2% (95% CI 8.1 to 10.3%)). This means that around 1 in
Table 1 Baseline characteristics and details of follow-up for coronary heart disease (CHD), by body mass index.
Body mass index (kg/m2)
<20 20 to 24.9 25 to 29.9 30 to 34.9 ≥35 All
n = 44,787 n = 509,874 n = 420,712 n = 145,551 n = 58,015 n = 1,178,939
Baseline characteristics
Age (years), mean (SD) 55.9 (5.0) 55.8 (4.8) 56.2 (4.8) 56.2 (4.8) 55.6 (4.6) 56.0 (4.8)
Current smoker,% 32.6 21.5 19.1 16.8 15.0 20.2
Lowest third of socioeconomic status,% 32.4 28.1 32.7 38.4 44.9 32.0
Non-drinker of alcoholic beverage,% 26.4 19.0 22.8 29.8 37.5 22.9
Rarely/never engage in strenuous physical activity,% 47.0 41.6 48.8 57.4 64.1 47.4
Follow-up (excluding first 4 years)
Person-years for first coronary event (1,000s) 223 2,592 2,105 716 280 5,916
Person-years for CHD death (1,000s) 225 2,618 2,134 729 285 5,992
Women with first coronary event, n 999 11,005 12,498 5,363 2,600 32,465
Women with CHD as underlying cause of death, n 117 811 856 377 270 2,431
Percentages are calculated based on women with complete information for that specific variable.
Figure 1 Adjusted relative risk (95% group-specific confidence interva; g-sCI) for coronary heart disease (CHD) incidence and mortality
in relation to body mass index (BMI). Relative risks (RRs) are plotted against mean BMI in the corresponding BMI category. RR = 1.0 for
women with BMI of 22.5 to 24.9 kg/m2. CHD cumulative incidence and mortality over 20 years from the age of 55 years. Spaces are provided
between incidence and mortality RRs within each BMI category to distinguish their corresponding CIs.
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6 (95% CI 1 in 5 to 7) women with a BMI of 34 kg/m2,
compared with 1 in 11 (95% CI 1 in 10 to 12) women with
a BMI of 21 kg/m2, had a first coronary event over a 20-
year period from age 55 years.
Assessing the relation between BMI and 20-year cumu-
lative incidence of CHD from age 55 to 74 years by
smoking, alcohol consumption, physical activity, and
socioeconomic status, the increasing incidence of the dis-
ease associated with rising BMI levels was apparent in all
subgroups (Figure 3; see Additional file 1, Table S2 for
further details). Of all factors examined, current smoking
had the greatest effect on CHD incidence. Current smo-
kers who were neither overweight nor obese had similar
CHD risks to severely obese never smokers: the cumula-
tive incidence was 16.1% (95% CI 14.9 to 17.3%) for cur-
rent smokers with BMI less than 25 kg/m2 (mean BMI =
22.6 kg/m2) and 14.9% (95% CI 12.8 to 16.9%) for never
smokers with BMI of 35 kg/m2 or over (mean BMI =
38.7 kg/m2). The greatest cumulative risk of CHD from
age 55 to 74 years was seen for current smokers with
BMI of 35 kg/m2 or over (26.9% (95% CI 21.1 to 32.4%)),
suggesting that about 1 in every 4 such women (95% CI 1
in 3 to 5) had a first coronary event in the 20-year period
from the age of 55 years. The effect of obesity was also
apparent for alcohol drinkers and non-drinkers alike,
with the greatest cumulative CHD risk found for non-
drinkers with BMI of 35 kg/m2 or over, and the lowest
for drinkers with BMI of less than 25 kg/m2.
Correction for measurement error and changes in
BMI over time had little effect on the relative risk esti-
mates associated with increasing BMI (see Additional
file 1, Table S3). The relative risk for incident CHD per
5-unit increase in BMI was 1.23 (95% CI 1.22 to 1.25)
before and 1.24 (95% CI 1.23 to 1.26) after the correc-
tion was applied. Limiting the analysis to women with
no missing value for any covariate had little effect on
the relative risk (1.23 (95% CI 1.22 to 1.25)). When we
accounted for competing causes of death, the 20-year
cumulative risks were only slightly reduced (see Addi-
tional file 1, Figure S3).
Figure 2 Cumulative incidence (95% confidence interval; CI) of coronary heart disease (CHD) over 5 years in relation to body mass
index (BMI) and attained age. Cumulative incidences are plotted against mean BMI in the corresponding BMI category.
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Discussion
In this large cohort of middle-aged UK women, about one
in every eight women will have a first hospital admission
for or have died from CHD in the 20 years from the age of
55 to 74 years. The cumulative incidence of CHD over 20
years increased progressively with BMI, from about one in
Figure 3 The 20-year cumulative coronary heart disease (CHD) incidence (95% confidence interval; CI) from age 55 to 74 years in
relation to body mass index (BMI) and other risk factors. Cumulative incidences are plotted against mean BMI in the corresponding BMI
category.
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eleven women with a BMI of 21 kg/m2 to one in six
women with a BMI of 34 kg/m2. Similar trends of progres-
sively increasing CHD incidence with increasing BMI were
seen across the age groups studied, and in smokers and
non-smokers, alcohol drinkers and non-drinkers, women
who were active and inactive, and in women from upper
and lower socioeconomic groups.
Unlike the association between BMI and incident dis-
ease, there was a J-shaped relationship between BMI and
CHD mortality. Our findings are consistent with findings
from other large-scale prospective studies for CHD mor-
tality [6-8,33] and for all-cause mortality (where a sub-
stantial proportion of deaths are due to vascular causes)
[6,8,34-36]. It is possible that the relation with BMI varies
for fatal and incident CHD outcomes [9-11], but these
findings have been based on relatively small numbers of
disease events. No other large-scale study has directly
compared the BMI-CHD relationship for incident and
fatal CHD. In our study, the relative risks for those with
the lowest and highest BMI values were greater in magni-
tude for CHD mortality than for incident coronary event,
suggesting that case fatality rates are higher in both lean
and obese women than in those with a BMI within the
normal or overweight range. The underlying reason for
the excess vascular deaths associated with low BMI
remains unclear. Although we excluded early disease
events, reverse causation remains a possibility, as the
effect of preclinical illness in those with low BMI on fatal
outcomes may persist over a long period [36]. However,
this confounding effect was not apparent for incident
CHD events as we found no evidence of an increased
incidence rate associated with low BMI. Thus, our find-
ings provide evidence for the importance of greater adip-
osity in the occurrence of a CHD event. In other studies
that investigated the association between BMI and inci-
dent CHD [9,12-15,17,37], results were broadly similar to
those found here, but generally lacked power to describe
reliably the relation between BMI and incident CHD
across a wide range of values and important subgroups in
the population.
BMI is known to vary with a number of factors, includ-
ing age, smoking, physical activity, alcohol consumption,
and socioeconomic status [8,15,38], which are also asso-
ciated with CHD risk [2,3]. We took these potential con-
founding factors into account in our analyses. Further, our
results suggest that obesity remains as important a risk fac-
tor for incident disease in older as in younger women in
the age group studied. The effect of a 10 kg/m2 increment
in BMI on CHD incidence was comparable with that of a
5-year increase in chronological age. We also found that
the increasing CHD risk with increasing BMI was consis-
tently seen for current and never smokers, alcohol drinkers
and non-drinkers, physically active and inactive women,
and women in the upper and lower socioeconomic groups.
Few studies have compared the combined effect of obesity
and smoking on heart disease [15,18,19,37,39], and our
results indicate a very large absolute risk that one in four
current smokers who are also obese will develop a coron-
ary event in the 20 years from the age of 55 years. Women
drinkers in this cohort consume only low to moderate
amounts of alcohol, and such consumption has been
known to be associated with lower CHD risk [40]; never-
theless, CHD risk increased with BMI in both drinkers and
non-drinkers.
Our findings could have important implications for pub-
lic health, and suggest that reducing this obesity-associated
CHD burden will probably require population-level pre-
ventive strategies. One such approach suggests shifting the
population distribution of a modifiable risk factor down-
wards to prevent the occurrence of CHD [5]. However,
shifting the population distribution of BMI downwards
may have unintended consequences, considering that
large-scale prospective studies that looked at fatal disease
have shown increased CHD mortality risks with both high
and low BMI levels [6-8]. However, our findings suggest
that there is no such increased risk at the lower end of the
BMI range for incident outcomes. Because most CHD
events occurred in non-obese women, and small incre-
ments in BMI were associated with increasing incidence of
the disease, small shifts in BMI distribution could poten-
tially have a large effect on reducing the CHD burden
both in the whole population and in important subgroups
defined by age, smoking, physical activity level, alcohol
consumption, and socioeconomic class.
There are some limitations to consider in interpreting
our findings. We used self-reported weight and height at
baseline to calculate BMI, and this can change over time.
However, the correlation of measured and self-reported
data for BMI is high, and correction for both measure-
ment error and changes over time did not materially alter
our results. We assessed only BMI, an indicator of total
adiposity, but abdominal adiposity may also confer addi-
tional CHD risk [13,15]. Our findings included women
only, but there is little to suggest that the relation between
BMI and CHD differs between men and women
[14,15,37]. However, the absolute risks may not be directly
applicable to women in different populations. Allowing for
competing causes of death hardly changed the 20-year
incidence rates. Further, CHD may be clinically under-
diagnosed in women [41]. However, mediating factors
such as hypertension and dyslipidemia are known to
increase with BMI [8,15] and so the proportion of undiag-
nosed cases may be higher at the higher than the lower
end of the BMI distribution. Thus, our estimates of the
relative difference in incidence rates between lower and
higher BMI levels are likely to be conservative. Study parti-
cipants were recruited when they were invited for routine
breast cancer screening by a nationwide program. At the
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time the cohort was recruited, study participants repre-
sented one in four of the UK women in the target age
range [20], so our findings are likely to be relevant to a
large proportion of middle-aged women.
Conclusions
The effect of obesity on CHD was substantial in this
cohort of women, and the association was consistently
seen in various subgroups defined by their age, smoking,
physical activity, alcohol consumption, and socioeco-
nomic class. Because most CHD events occurred in
non-obese women, and even small increments in BMI
were associated with increasing incidence of the disease,
small shifts in the population distribution of BMI may
potentially have a large effect on reducing the CHD bur-
den in the population.
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